Efficacy of COVID-19 Vaccination in People with Follicular Lymphoma and Waldenström Macroglobulinaemia – A Prospective Cohort Study
Not Applicable
Active, not recruiting
- Conditions
- Follicular LymphomaWaldenstrom MacroglobulinaemiaBlood - Haematological diseasesCancer - Lymphoma (non Hodgkin's lymphoma) - Low grade lymphoma
- Registration Number
- ACTRN12621001202853
- Lead Sponsor
- Concord Repatriation General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 85
Inclusion Criteria
1. Patient with low grade FL treated with immunochemotherapy
2. Patients with FL who are treatment-naïve.
3. Patients with WM currently on treatment with a BTKi
4. Patients with WM during or following treatment with standard immunochemotherapy
5. Patients with WM who are treatment-naïve.
6. A group of healthy volunteers who are controls
Exclusion Criteria
1. Patients with additional medical co-morbidities and/or medications that compromise their immune function (e.g. inflammatory bowel disease, rheumatoid arthritis, SLE, HIV, high dose prednisolone for reasons other than lymphoma treatment). If there is any doubt, the final decision will rest with the PI.
2. Those not wishing to consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method